American Oriental Bioengineering, Inc. announced plans to offer $85 million in Convertible Senior Notes, due 2015. At the same time, the company has entered into an agreement to use $30 million of the proceeds to buy back shares of its own stock, in part to counteract a decline in price of its shares caused by the announcement and its subsequent dilution of existing shares. More details...

Stock Symbol: (NYSE: AOB)